ARCHIVES

Marijuana-Derived Drug Less Effective Than Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 3 | March 29, 2002

Download PDF Visit The Full Archive

Related Articles

Government Remains open Under Budget Agreement; New Deadlines Are Oct. 5 & 19

October 5, 1990

Cancer Epidemiology Hampered By Bureaucratic Delays, Lack of Cooperation, NCI Group Says

September 29, 1978

NCI Faces $32 Million Budget Cut In FY 2006; NIH Tells Grantees To Expect 2.35 Percent Reduction In Award Funds.

January 13, 2006

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011